Related Experiment Video
Updated: Jul 18, 2026

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain
Published on: May 12, 2018
Sudden death of a child treated with imipramine. Case study
1Division of Child and Adolescent Psychiatry, University of Washington, Seattle 98105, USA. Cvarley@u.washington.edu
Insights
This case study reports a child
Area of Science:
- Pediatric pharmacology
- Cardiovascular safety in children
Background:
- Tricyclic antidepressants (TCAs) are used to treat various pediatric conditions.
- Concerns exist regarding the cardiovascular safety of TCAs in pediatric populations.
Observation:
- A case study details the sudden death of an 8-year-old child treated with imipramine and dextroamphetamine.
- The child exhibited potential cardiovascular abnormalities after initiating imipramine treatment.
Findings:
- This report documents an eighth case of sudden death in a child associated with tricyclic antidepressant use since 1990.
- The findings suggest a potential link between imipramine treatment and adverse cardiovascular events in children.
Implications:
- This case underscores the need for careful cardiovascular monitoring in children prescribed tricyclic antidepressants.
- Further research is warranted to elucidate the mechanisms and risks of TCAs in pediatric patients.
Abstract:
Since 1990, there have been seven reported cases of sudden death in children treated with tricyclic antidepressants. This case study describes the sudden death of an additional child (8 years 9 months old, 29 kg in weight) treated with a tricyclic antidepressant, imipramine (100 mg orally, twice daily), and dextroamphetamine (10 mg orally every morning). Prior to death, there were signs of possible cardiovascular abnormalities after treatment was begun with imipramine. The report adds to the concern over the use of tricyclics in children.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug Dosing: Infants and Children
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Electroconvulsive Therapy

